Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Wockhardt UK Ltd, Ash Road North, Wrexham LL13 9UF, UK
Ceftazidime 1g Powder for solution for injection.
| Pharmaceutical Form |
|---|
|
Powder for solution for injection (Powder for injection). White to cream coloured, crystalline powder. |
Each vial contains ceftazidime 1g (as pentahydrate).
Excipient with known effect: Each gram of ceftazidime contains approximately 52mg (2.26mmol) of sodium.
For the full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Ceftazidime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death. |
| List of Excipients |
|---|
|
Sodium carbonate (anhydrous sterile) |
Packs of one, five or ten Type II colourless glass 10ml vials stoppered with coated rubber stopper, capped with flip-off cap.
Not all pack sizes may be marketed.
Wockhardt UK Ltd, Ash Road North, Wrexham LL13 9UF, UK
PL 29831/0031
15 October 2007
| Drug | Countries | |
|---|---|---|
| CEFTAZIDIME | Nigeria |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.